Profile data is unavailable for this security.
About the company
Valeo Pharma Inc. is a Canadian pharmaceutical company. The Company acquires, or in-licenses branded pharmaceuticals and hospital specialty products for sale in Canada. The Company is engaged in the commercialization of prescription products in Canada with a focus on respiratory/allergy, ophthalmology and hospital specialty products. Its respiratory/allergy products include Enerzair Breezhaler, Atectura Breezhaler and Allerject. The ophthalmology products include Xiidra and Simbrinza. Its specialty products include Redesca, Onstryv, M-Eslon, Yondelis and Ametop Gel 4%. The Company's wholly owned subsidiary is VPI Pharmaceuticals Inc.
- Revenue in CAD (TTM)54.29m
- Net income in CAD-28.43m
- Incorporated2003
- Employees100.00
- LocationValeo Pharma Inc16667 Hymus BlvdKIRKLAND H9H 4R9CanadaCAN
- Phone+1 (514) 693-8832
- Fax+1 (514) 693-8832
- Websitehttps://valeopharma.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Crescita Therapeutics Inc | 17.52m | -1.99m | 8.50m | 78.00 | -- | 0.4612 | -- | 0.4851 | -0.0977 | -0.0977 | 0.8651 | 0.9432 | 0.6602 | 1.22 | 3.94 | -- | -7.48 | -0.2457 | -9.42 | -0.3059 | 59.15 | 63.41 | -11.33 | -0.3518 | 2.54 | -- | 0.0625 | -- | -25.52 | 1.05 | -330.39 | -- | -1.58 | -- |
Khiron Life Sciences Corp | 16.14m | -30.66m | 9.30m | 310.00 | -- | 0.3205 | -- | 0.5761 | -0.1674 | -0.1674 | 0.085 | 0.1248 | 0.3078 | 1.33 | 3.90 | 52,055.68 | -58.47 | -- | -69.10 | -- | 19.51 | -- | -190.00 | -- | 0.9133 | -- | 0.0864 | -- | 59.60 | -- | -37.81 | -- | -- | -- |
Valeo Pharma Inc | 54.29m | -28.43m | 9.87m | 100.00 | -- | -- | -- | 0.1818 | -0.3255 | -0.3255 | 0.6249 | -0.4765 | 1.23 | 3.53 | 12.39 | 434,296.00 | -64.52 | -64.35 | -215.78 | -113.22 | 21.38 | 23.88 | -52.37 | -69.71 | 0.2974 | -1.33 | 3.51 | -- | 94.31 | 65.20 | -8.01 | -- | 76.61 | -- |
Telo Genomics Corp | 0.00 | -3.07m | 10.34m | -- | -- | 8.58 | -- | -- | -0.0468 | -0.0468 | 0.00 | 0.0169 | 0.00 | -- | -- | -- | -195.00 | -85.03 | -222.53 | -113.86 | -- | -- | -- | -- | -- | -- | 0.0263 | -- | -- | -- | -33.66 | -- | 24.41 | -- |
Medicure Inc | 21.69m | -921.00k | 10.96m | 25.00 | -- | 0.5508 | 8.79 | 0.5051 | -0.0893 | -0.0893 | 2.01 | 1.91 | 0.7486 | 2.52 | 4.36 | 867,760.00 | -3.19 | -13.42 | -4.43 | -18.28 | 64.48 | 61.87 | -4.25 | -27.38 | 1.55 | -19.84 | 0.0266 | -- | -5.94 | -5.71 | -167.55 | -- | -28.82 | -- |
Willow Biosciences Inc | 1.17m | -13.03m | 12.09m | 19.00 | -- | 3.44 | -- | 10.31 | -0.105 | -0.105 | 0.0094 | 0.0276 | 0.0944 | -- | 5.23 | 61,684.21 | -104.98 | -- | -122.40 | -- | -- | -- | -1,111.69 | -- | 2.18 | -- | 0.3856 | -- | 42.75 | -- | 12.05 | -- | -- | -- |
Data as of May 09 2024. Currency figures normalised to Valeo Pharma Inc's reporting currency: Canadian Dollar CAD